Comparative real-world outcomes of LifeStream and Viabahn VBX balloon-expandable covered stents for iliac artery occlusive disease
PURPOSE: Balloon-expandable covered stents (CSs) are increasingly used for complex iliac artery occlusive disease, but direct comparative data among CS platforms remain limited. This study compared 1-year restenosis and clinical outcomes between the LifeStream and Viabahn VBX CSs in patients undergoing endovascular treatment (EVT). METHODS: This multicenter retrospective study included 226 patients who underwent EVT for symptomatic iliac artery occlusive disease using either the LifeStream CS (n = 95) or Viabahn VBX CS (n = 131). Outcomes included restenosis, clinically driven target lesion revascularization (CD-TLR), re-occlusion, conversion to bypass surgery, and perioperative complications (POCs). Between-group comparisons were performed using inverse probability of treatment weighting (IPTW) based on propensity scores. RESULTS: One-year follow-up data were available for 163 of 226 patients (72.1%), and 10 restenosis events occurred during follow-up. After IPTW adjustment, the balance of measured covariates was substantially improved. The estimated 1-year freedom from restenosis was 95.8% (95% confidence interval [CI], 93.1-98.6%) in the LifeStream group and 95.8% (95% CI, 93.1-98.6%) in the Viabahn VBX group, with no statistically significant between-group difference (p = 0.99). No significant differences were detected in freedom from CD-TLR (99.2% [95% CI, 98.0-100.0%] vs. 96.7% [95% CI, 94.3-99.2%]; p = 0.13), re-occlusion (100.0% [95% CI, 100.0-100.0%] vs. 98.1% [95% CI, 96.3-99.9%]; p = 0.091), conversion to bypass surgery (100.0% [95% CI, 100.0-100.0%] vs. 98.2% [95% CI, 96.4-100.0%]; p = 0.083), or POCs. CONCLUSION: In this IPTW-adjusted multicenter retrospective study, no statistically significant differences in 1-year restenosis or other clinical outcomes were detected between the LifeStream and Viabahn VBX balloon-expandable CSs. These findings should be considered hypothesis-generating because of the small number of events, incomplete follow-up, and potential residual confounding.
Authors
- Kenji Ogata (ORCID: https://orcid.org/0000-0002-8563-6854)
- Yoshimitsu Soga (ORCID: https://orcid.org/0000-0003-1931-5769)
- Yusuke Tomoi (ORCID: https://orcid.org/0000-0002-8939-0222)
- Kenji Andò (ORCID: https://orcid.org/0000-0003-0699-4248)
- Mitsuyoshi Takahara (ORCID: https://orcid.org/0000-0001-5105-041X)
- Tatsuro Takei (ORCID: https://orcid.org/0000-0001-8733-473X)
Institutions
- Kokura Memorial Hospital (JP)
- Miyazaki Medical Association Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- CVIR Endovascular
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s42155-026-00802-8
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00